BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36890092)

  • 1. Heme oxygenase-1 inhibits the cytotoxicity of natural killer cells to acute myeloid leukemia by downregulating human leukocyte antigen-C.
    Feng C; Zhang T; Pan C; Kang Q; Wang L; Liu X; Shang Q; Chen S; Hu T; Wang J
    Cytotherapy; 2023 Jul; 25(7):728-738. PubMed ID: 36890092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heme oxygenase 1 overexpression induces immune evasion of acute myeloid leukemia against natural killer cells by inhibiting CD48.
    Zhang T; Fang Q; Liu P; Wang P; Feng C; Wang J
    J Transl Med; 2022 Sep; 20(1):394. PubMed ID: 36058936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heme oxygenase-1 suppresses the apoptosis of acute myeloid leukemia cells via the JNK/c-JUN signaling pathway.
    Lin X; Fang Q; Chen S; Zhe N; Chai Q; Yu M; Zhang Y; Wang Z; Wang J
    Leuk Res; 2015 May; 39(5):544-52. PubMed ID: 25828744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of CD158 and NKG2A Inhibitory Receptors and Underexpression of NKG2D and NKp46 Activating Receptors on NK Cells in Acute Myeloid Leukemia.
    Sandoval-Borrego D; Moreno-Lafont MC; Vazquez-Sanchez EA; Gutierrez-Hoya A; López-Santiago R; Montiel-Cervantes LA; Ramírez-Saldaña M; Vela-Ojeda J
    Arch Med Res; 2016 Jan; 47(1):55-64. PubMed ID: 26876298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cells in acute myeloid leukemia patients: from phenotype to transcriptomic analysis.
    Venton G; Labiad Y; Colle J; Fino A; Afridi S; Torres M; Monteuil S; Loriod B; Fernandez-Nunez N; Farnault L; Suchon P; Mattei JC; Rihet P; Bergon A; Nguyen C; Baier C; Costello R
    Immunol Res; 2016 Dec; 64(5-6):1225-1236. PubMed ID: 27481509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer cells and acute myeloid leukemia: promises and challenges.
    Rahmani S; Yazdanpanah N; Rezaei N
    Cancer Immunol Immunother; 2022 Dec; 71(12):2849-2867. PubMed ID: 35639116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heme oxygenase-1 plays a crucial role in chemoresistance in acute myeloid leukemia.
    Zhe N; Wang J; Chen S; Lin X; Chai Q; Zhang Y; Zhao J; Fang Q
    Hematology; 2015 Aug; 20(7):384-91. PubMed ID: 26218201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural Killer Immunotherapy for Minimal Residual Disease Eradication Following Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia.
    Hattori N; Nakamaki T
    Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31027331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fc-engineered anti-CD33 monoclonal antibody potentiates cytotoxicity of membrane-bound interleukin-21 expanded natural killer cells in acute myeloid leukemia.
    Mani R; Rajgolikar G; Nunes J; Zapolnik K; Wasmuth R; Mo X; Byrd JC; Lee DA; Muthusamy N; Vasu S
    Cytotherapy; 2020 Jul; 22(7):369-376. PubMed ID: 32303428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heme oxygenase-1: A new druggable target in the management of chronic and acute myeloid leukemia.
    Salerno L; Romeo G; Modica MN; Amata E; Sorrenti V; Barbagallo I; Pittalà V
    Eur J Med Chem; 2017 Dec; 142():163-178. PubMed ID: 28756878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crucial role of heme oxygenase-1 in the sensitivity of acute myeloid leukemia cell line Kasumi-1 to ursolic acid.
    Ma D; Fang Q; Li Y; Wang J; Sun J; Zhang Y; Hu X; Wang P; Zhou S
    Anticancer Drugs; 2014 Apr; 25(4):406-14. PubMed ID: 24413389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulatory Drugs Exert Anti-Leukemia Effects in Acute Myeloid Leukemia by Direct and Immunostimulatory Activities.
    Le Roy A; Prébet T; Castellano R; Goubard A; Riccardi F; Fauriat C; Granjeaud S; Benyamine A; Castanier C; Orlanducci F; Ben Amara A; Pont F; Fournié JJ; Collette Y; Mege JL; Vey N; Olive D
    Front Immunol; 2018; 9():977. PubMed ID: 29780393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer cell immune escape in acute myeloid leukemia.
    Lion E; Willemen Y; Berneman ZN; Van Tendeloo VF; Smits EL
    Leukemia; 2012 Sep; 26(9):2019-26. PubMed ID: 22446501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal evolution including partial loss of human leukocyte antigen genes favoring extramedullary acute myeloid leukemia relapse after matched related allogeneic hematopoietic stem cell transplantation.
    Stölzel F; Hackmann K; Kuithan F; Mohr B; Füssel M; Oelschlägel U; Thiede C; Röllig C; Platzbecker U; Schetelig J; Illmer T; Schaich M; Seliger B; Hartmann A; Baretton G; Zietz C; Ehninger G; Schrock E; Bornhäuser M
    Transplantation; 2012 Apr; 93(7):744-9. PubMed ID: 22314337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Siglec-7 is an indicator of natural killer cell function in acute myeloid leukemia.
    Yang L; Feng Y; Wang S; Jiang S; Tao L; Li J; Wang X
    Int Immunopharmacol; 2021 Oct; 99():107965. PubMed ID: 34273636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the inhibitory KIR ligand HLA-Bw4 and HLA-C expression levels in the recognition of leukemic cells by Natural Killer cells.
    Verheyden S; Ferrone S; Mulder A; Claas FH; Schots R; De Moerloose B; Benoit Y; Demanet C
    Cancer Immunol Immunother; 2009 Jun; 58(6):855-65. PubMed ID: 18841361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1.
    Venstrom JM; Pittari G; Gooley TA; Chewning JH; Spellman S; Haagenson M; Gallagher MM; Malkki M; Petersdorf E; Dupont B; Hsu KC
    N Engl J Med; 2012 Aug; 367(9):805-16. PubMed ID: 22931314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low expression of GFI-1 Gene is associated with Panobinostat-resistance in acute myeloid leukemia through influencing the level of HO-1.
    Cheng B; Tang S; Zhe N; Ma D; Yu K; Wei D; Zhou Z; Lu T; Wang J; Fang Q
    Biomed Pharmacother; 2018 Apr; 100():509-520. PubMed ID: 29494986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering CAR-NK cells to secrete IL-15 sustains their anti-AML functionality but is associated with systemic toxicities.
    Christodoulou I; Ho WJ; Marple A; Ravich JW; Tam A; Rahnama R; Fearnow A; Rietberg C; Yanik S; Solomou EE; Varadhan R; Koldobskiy MA; Bonifant CL
    J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34896980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NK cell defects: implication in acute myeloid leukemia.
    D'Silva SZ; Singh M; Pinto AS
    Front Immunol; 2023; 14():1112059. PubMed ID: 37228595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.